Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VolitionRX Ltd (NYSE MKT LLC:VNRX)

3.52
Delayed Data
As of May 25
 -0.19 / -5.12%
Today’s Change
3.05
Today|||52-Week Range
5.86
-22.98%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$92.8M

Company Description

VolitionRX Ltd. engages in the development of blood-based cancer tests. Its tests are based on the science of Nucleosomics, which identifies and measures nucleosomes in the bloodstream or other bodily fluid. Its product Nu.Q is a Colorectal Cancer Screening Triage Test. The company was founded on August 5, 2010 and is headquartered in Singapore.

Contact Information

VolitionRX Ltd.
1 Scotts Road
Singapore Central Singapore 228208
P:
Investor Relations:
(646) 650-1351

Employees

Shareholders

Individual stakeholders22.94%
Other institutional20.94%
Mutual fund holders1.21%

Top Executives

Cameron John ReynoldsPresident, Chief Executive Officer & Director
David Vanston CecilChief Financial Officer
Jason Bradley TerrellChief Medical Officer & Head-US Operations
Jacob Vincent MicallefChief Scientific Officer
Louise DayChief Marketing & Communications Officer